Cargando…

Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database

BACKGROUND: The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated comorbidities, including diabetes mellitus, is well established. As diabetes may add risk to the perioperative period, we sought to character...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonard-Murali, Shravan, Nasser, Hassan, Ivanics, Tommy, Shakaroun, Dania, Genaw, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223599/
https://www.ncbi.nlm.nih.gov/pubmed/31598899
http://dx.doi.org/10.1007/s11695-019-04175-x
_version_ 1783533770755801088
author Leonard-Murali, Shravan
Nasser, Hassan
Ivanics, Tommy
Shakaroun, Dania
Genaw, Jeffrey
author_facet Leonard-Murali, Shravan
Nasser, Hassan
Ivanics, Tommy
Shakaroun, Dania
Genaw, Jeffrey
author_sort Leonard-Murali, Shravan
collection PubMed
description BACKGROUND: The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated comorbidities, including diabetes mellitus, is well established. As diabetes may add risk to the perioperative period, we sought to characterize perioperative outcomes of these surgical procedures in diabetic patients. METHODS: Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, we identified patients who underwent LSG and LRYGB between 2015 and 2017, grouping by non-diabetics (NDM), non-insulin-dependent diabetics (NIDDM), and insulin-dependent diabetics (IDDM). Primary outcomes included serious adverse events, 30-day readmission, 30-day reoperation, and 30-day mortality. Univariate and multivariable analyses were used to evaluate the outcome in each diabetic cohort. RESULTS: Multivariable analysis of patients who underwent LSG (with NDM patients as reference) showed higher 30-day mortality (NIDDM AOR = 1.52, p = 0.043; IDDM AOR = 1.91, p = 0.007) and risk of serious adverse events (NIDDM AOR = 1.15, p < 0.001; IDDM AOR = 1.58, p < 0.001) in the diabetic versus NDM groups. Multivariable analysis of patients who underwent LRYGB (with NDM patients as reference) showed higher risk of serious adverse events (NIDDM AOR = 1.09, p = 0.014; IDDM AOR = 1.43, p < 0.001) in the diabetic versus NDM groups. CONCLUSIONS: Diabetics who underwent LSG and LRYGB had higher rates of several perioperative complications compared with non-diabetics. IDDM had a stronger association with several perioperative complications compared with NIDDM. This increase in morbidity and mortality is modest and should be weighed against the real benefits of bariatric surgery in patient with obesity and diabetes mellitus.
format Online
Article
Text
id pubmed-7223599
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72235992020-05-15 Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database Leonard-Murali, Shravan Nasser, Hassan Ivanics, Tommy Shakaroun, Dania Genaw, Jeffrey Obes Surg Original Contributions BACKGROUND: The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated comorbidities, including diabetes mellitus, is well established. As diabetes may add risk to the perioperative period, we sought to characterize perioperative outcomes of these surgical procedures in diabetic patients. METHODS: Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, we identified patients who underwent LSG and LRYGB between 2015 and 2017, grouping by non-diabetics (NDM), non-insulin-dependent diabetics (NIDDM), and insulin-dependent diabetics (IDDM). Primary outcomes included serious adverse events, 30-day readmission, 30-day reoperation, and 30-day mortality. Univariate and multivariable analyses were used to evaluate the outcome in each diabetic cohort. RESULTS: Multivariable analysis of patients who underwent LSG (with NDM patients as reference) showed higher 30-day mortality (NIDDM AOR = 1.52, p = 0.043; IDDM AOR = 1.91, p = 0.007) and risk of serious adverse events (NIDDM AOR = 1.15, p < 0.001; IDDM AOR = 1.58, p < 0.001) in the diabetic versus NDM groups. Multivariable analysis of patients who underwent LRYGB (with NDM patients as reference) showed higher risk of serious adverse events (NIDDM AOR = 1.09, p = 0.014; IDDM AOR = 1.43, p < 0.001) in the diabetic versus NDM groups. CONCLUSIONS: Diabetics who underwent LSG and LRYGB had higher rates of several perioperative complications compared with non-diabetics. IDDM had a stronger association with several perioperative complications compared with NIDDM. This increase in morbidity and mortality is modest and should be weighed against the real benefits of bariatric surgery in patient with obesity and diabetes mellitus. Springer US 2019-10-09 2020 /pmc/articles/PMC7223599/ /pubmed/31598899 http://dx.doi.org/10.1007/s11695-019-04175-x Text en © Springer Science+Business Media, LLC, part of Springer Nature 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Contributions
Leonard-Murali, Shravan
Nasser, Hassan
Ivanics, Tommy
Shakaroun, Dania
Genaw, Jeffrey
Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
title Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
title_full Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
title_fullStr Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
title_full_unstemmed Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
title_short Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
title_sort perioperative outcomes of roux-en-y gastric bypass and sleeve gastrectomy in patients with diabetes mellitus: an analysis of the metabolic and bariatric surgery accreditation and quality improvement program (mbsaqip) database
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223599/
https://www.ncbi.nlm.nih.gov/pubmed/31598899
http://dx.doi.org/10.1007/s11695-019-04175-x
work_keys_str_mv AT leonardmuralishravan perioperativeoutcomesofrouxenygastricbypassandsleevegastrectomyinpatientswithdiabetesmellitusananalysisofthemetabolicandbariatricsurgeryaccreditationandqualityimprovementprogrammbsaqipdatabase
AT nasserhassan perioperativeoutcomesofrouxenygastricbypassandsleevegastrectomyinpatientswithdiabetesmellitusananalysisofthemetabolicandbariatricsurgeryaccreditationandqualityimprovementprogrammbsaqipdatabase
AT ivanicstommy perioperativeoutcomesofrouxenygastricbypassandsleevegastrectomyinpatientswithdiabetesmellitusananalysisofthemetabolicandbariatricsurgeryaccreditationandqualityimprovementprogrammbsaqipdatabase
AT shakaroundania perioperativeoutcomesofrouxenygastricbypassandsleevegastrectomyinpatientswithdiabetesmellitusananalysisofthemetabolicandbariatricsurgeryaccreditationandqualityimprovementprogrammbsaqipdatabase
AT genawjeffrey perioperativeoutcomesofrouxenygastricbypassandsleevegastrectomyinpatientswithdiabetesmellitusananalysisofthemetabolicandbariatricsurgeryaccreditationandqualityimprovementprogrammbsaqipdatabase